Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CDRT15P14 is annotated as a pseudogene related to the CDRT15 gene family[5]. Pseudogenes are genetic elements resembling functional genes but that have lost their protein-coding potential or biological activity, often due to frameshifts, premature stop codons, or other disruptive mutations[1]. There is no evidence that CDRT15P14 encodes a functional protein or plays a direct role as a drug target, receptor, enzyme, or other key molecular entity in human biology. CDRT15P14 has not been associated with any known biological function, disease mechanism, or pharmacological interaction. It is best understood as a genomic remnant arising from gene duplication events and is not considered a therapeutic target[1][5]. Important note: - The parental gene *CDRT15* itself has unknown function and is the subject of ongoing research, but specifically, the designation "pseudogene" (as with CDRT15P14) indicates lack of known protein-coding or therapeutic functionality[1][5]. - No reference to signal transduction, enzyme activity, transporter role, or involvement in common disease mechanisms exists for CDRT15P14. - The string "CDRT15P14" is correctly formatted and does not appear to be misspelled, but the target is not a functional gene, protein, or therapeutic target. Summary: CDRT15P14 is a non-functional pseudogene with no known therapeutic, biological, or clinical relevance[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CMT1A duplicated region transcript 15 pseudogene 14 (CDRT15P14).